How cancer treatments are made available

If you are diagnosed with cancer, a team of specialists meet to talk about the best treatment for you. They are called a multidisciplinary team (MDT).

The MDT looks at national treatment guidelines or the latest evidence for the type of cancer you have.

This information is about access to all types of cancer treatments. When we use the word ‘treatment’, this also includes drugs used to treat cancer.

How cancer treatments are developed

Cancer treatments are usually developed over years of careful research. Researchers test new treatments to find out:

  • if and how the treatment works
  • whether it improves quality of life
  • which cancers it can be used to treat
  • what the side effects are
  • how it compares to current treatments.

Every treatment has side effects, but research can tell us whether the benefits of the treatment outweigh the risks and side effects.

Until a new drug has a licence, it cannot be prescribed by the NHS. To get a licence, a treatment must show that the benefits outweigh the risks.

In the UK, the organisation that licenses drugs is called the Medicines and Healthcare products Regulatory Agency (MHRA). In Northern Ireland, drugs can also be licensed by the European Medicines Agency (EMA).

A drug is licensed to be used in a particular way, for a specific group of patients. For example, a drug that is licensed to treat breast cancer should not be used to treat any other type of cancer. If new research shows that the drug is also helpful in treating another type of cancer, the drug manufacturer has to apply for another licence.

Early Access to Medicines Scheme (EAMS)

Some drugs that have not yet been licensed may be available through the Early Access to Medicines Scheme (EAMS). This aims to give people access to drugs that have shown a benefit in research trials, but may still be part of ongoing research or waiting to be licensed. This means that researchers may not yet know how well a drug will work, or all the side effects.

If you think an EAMS drug might be suitable for you, your cancer doctor must agree and apply to the scheme for you. A list of drugs available through the scheme is available at gov.uk

If a treatment is not available in your area

If the treatment you need is not available in your area, the NHS may arrange for you to have it somewhere else. The rules about this vary depending where you live.

You can find out more about how this works in:

If a treatment is not available on the NHS

Most treatments and services that patients need are offered by the NHS. But in some cases, treatment is not available for patients with a particular need.

If a treatment is not available on the NHS, start by talking to your cancer doctor. It is important to understand the treatment and whether it is right for you.

This can depend on:

  • the type and stage of cancer you have
  • the side effects and risks of the treatment
  • the possible benefits of the treatment
  • any other treatments you have had
  • other treatments that are available.

If you and your doctor agree that you would benefit from the treatment, you can apply to the NHS for funding. The way you apply is different in England, Wales, Scotland and Northern Ireland. If a treatment is still unavailable, there may be other things you can do (see ‘Other things you can do if a treatment is not available’ below).

If you live in England

If you live in England and a treatment is not available in the NHS, your cancer doctor may make an Individual Funding Request (IFR) to NHS England. Or if the treatment is a drug, they may apply to NHS England’s Cancer Drugs Fund.

Applying to the Cancer Drugs Fund (CDF)

The Cancer Drugs Fund (CDF) will pay for some drugs in some situations. All new cancer drugs must be assessed by the National Institute for Health and Care Excellence (NICE). NICE will decide whether the new drug:

  • should be made available on the NHS straight away
  • should not be made available on the NHS
  • could be made available through the CDF.

NICE should make this decision within 90 days of a new drug being licensed for use in England.

If NICE decides that a drug should be provided through the CDF, it may be available to patients while NICE carries out further research into that particular drug.

This is usually because the drug has shown positive results in a research trial, but more information is needed to find out if the drug is effective enough to be provided on the NHS.

The drug will be made available through the CDF for a limited time, usually up to a maximum of 2 years. This gives NICE time to decide whether it should be provided on the NHS.

NHS England has an up-to-date list of the drugs that are currently available through the CDF. It explains which type of cancer the drug can be used for and at which stage.

If this matches your situation, your cancer doctor can apply online for you. The CDF will give your cancer doctor an online decision within 2 working days. Your doctor can arrange for you to start treatment at any time after the CDF agrees to pay for it. If you wait more than a month to start treatment, your doctor will need to apply again.

The CDF list is regularly updated, and new drugs are added. Sometimes drugs are taken off the CDF list. This might happen if NICE decides, after further research, that the drug should not be made available on the NHS. If you are getting a drug through the CDF and this happens, you can still complete your treatment. The company supplying the drug will pay for this.

If your situation is not covered by the CDF list, your cancer doctor may make an individual funding request instead.

Making an individual funding request

If a treatment is not provided by the NHS in your area, or is not available through the Cancer Drugs Fund, you can ask NHS England to pay for it. This is called an individual funding request (IFR).

An IFR form must be completed and sent to NHS England by someone from your healthcare team. This is usually the cancer doctor who will give you the treatment. Before they send the IFR, they will discuss it with you, unless you are too unwell.

The IFR form includes information about:

  • your medical situation
  • your previous treatments
  • the treatment your doctor is applying for
  • other standard treatments
  • the reasons why this treatment may be useful in your situation
  • any research that supports this.

Sometimes, your cancer doctor will include supporting information from you or someone you have chosen to represent you.

You can ask your cancer doctor for a copy of the completed IFR form. You and your GP will receive copies of any letters sent to your cancer doctor about the IFR. Or your cancer doctor will tell you both what is happening.

You can find the IFR form and policy on the NHS England website.

What happens next?

If NHS England approves your application, it will then be discussed by an independent panel of expert healthcare professionals who have not been involved in your care. The panel includes:

  • doctors
  • nurses
  • public health experts
  • pharmacists
  • NHS England representatives
  • members of the public.

All panel members are trained to assess IFRs fairly and thoroughly. Your cancer doctor will then be sent a letter to say whether:

  • your IFR will be discussed by the IFR panel at their next meeting
  • more information is needed about your situation
  • your IFR has been refused, and why this is.

If your IFR is approved by NHS England, the IFR panel will discuss it at their next meeting and decide whether to pay for the treatment. The panel meets regularly and will usually give you a decision within a few weeks. Urgent cases can be processed more quickly if needed. If the panel needs more information, it will contact your cancer doctor.

If your request is approved by the panel, your cancer doctor can then arrange for you to have the treatment. If the IFR panel decides not to pay for the treatment, your cancer doctor will explain why. They will tell you how you might be able to appeal against the decision, or what other treatment options may be available.

Making an appeal

If your cancer doctor has new evidence that could change the decision, they can ask the panel to discuss your IFR again. Or they can ask for a review of the IFR panel’s decision. You or your cancer doctor must do this in writing within 20 working days of getting the IFR panel’s decision letter. You can only ask for a review if your cancer doctor feels that the panel did not consider the medical evidence properly, or did not follow the correct process.

The review will decide 1 of the following:

  • The IFR panel’s decision was correct and the treatment will not be funded.
  • The IFR panel should discuss your request again within 10 working days.

If the final decision is not to pay for the drug, you cannot ask for another review. But you can use the NHS complaints procedure or write to the Parliamentary and Health Service Ombudsman. You can also seek legal advice.

There may also be other things you can do if a treatment is not available (see ‘Other things you can do if a treatment is not available’ below).

If you live in Scotland

If you live in Scotland and a treatment is not available on the NHS, your local NHS board may agree to pay for you to have it. This is arranged with the local NHS board by your cancer doctor. Your cancer doctor can tell you more about this.

Making a peer approved clinical system (PACS) request

If a licensed drug has not been recommended by the Scottish Medicines Consortium or the National Cancer Medicines Advisory Group, it will not be routinely available in Scotland.

If your cancer doctor feels strongly that you should have the drug, they can make a Peer Approved Clinical System (PACS) request to your local NHS board. This means asking a panel of experts to review whether the doctor can prescribe it. There are different processes (called tiers) involved, depending on each drug.

Making an individual patient treatment request (IPTR)

If a licensed drug has not been recommended by the Scottish Medicines Consortium or the National Cancer Medicines Advisory Group, it will not be routinely available in Scotland.

If your cancer doctor feels strongly that you should have the drug, they can make a Peer Approved Clinical System (PACS) request to your local NHS board. This means asking a panel of experts to review whether the doctor can prescribe it. There are different processes (called tiers) involved, depending on each drug.

PACS Tier 2

PACS Tier 2 is used to request licensed medicines and indications if:

  • the Scottish Medicines Consortium (SMC) has issued 'not recommended' advice for the medicine
  • your cancer doctor is requesting to use the medicine in a way that is not recommended by SMC
  • the medicine has been submitted to the SMC for review, but the SMC is yet to issue advice.

PACS Tier 1

PACS Tier 1 is used to access medicines for very rare diseases that are not recommended by the SMC for use in NHS Scotland.

What happens next?

An individual patient treatment request (IPTR) is used to request access to medicines for individual patients. They are used if:

  • the SMC has issued 'not recommended' advice because the drug manufacturer has not made a submission to SMC for this medicine and what it should be used for
  • the drug manufacturer has not yet made a submission to SMC for this medicine and what it should be used for.

Your cancer doctor completes the IPTR form, but they will discuss it with you first.

Making an appeal

If the panel decides not to pay for the drug, it will explain why. If your doctor thinks there is a good reason to, they can make an appeal to the National Review Panel on your behalf.

If the final decision is not to pay for the drug, you cannot appeal again. But you can use the NHS complaints procedure or write to the Scottish Public Service Ombudsman. You can also seek legal advice.

There may also be other things you can do if a treatment is not available (see ‘Other things you can do if a treatment is not available’ below).

If you live in Wales

If you live in Wales and a treatment is not available on the NHS, your cancer doctor can ask your local health board to pay for it. This is called an individual patient funding request (IPFR).

An IPFR form should be completed and signed by your doctor. This could be your cancer doctor or sometimes your GP. If you need help or advice about this, contact your Community Health Council.

You can find the IPFR form and policy on the NHS Wales website.

The IPFR form includes information about:

  • your medical situation
  • your previous treatments
  • the treatment your doctor is applying for
  • other standard treatments
  • the reasons why this treatment may be useful in your situation
  • any research that supports this.

Sometimes, your cancer doctor will include supporting information from you or someone you have chosen to represent you.

What happens next?

If something is missing from your IPFR form, it will be sent back to your doctor within 3 working days so they can complete it. Your doctor must then complete and re-submit the application form within 10 working days.

You and your doctor will then be sent a letter to say whether:

  • your IPFR will be discussed by the IPFR panel at their next meeting
  • more information is needed about your situation
  • your IPFR has been refused, is the reasons why.

If your IPFR is accepted, the IPFR panel will discuss it at the next meeting and decide whether to pay for the treatment. The panel meets regularly and will usually give you a decision within 5 working days of the meeting. If it needs more information, it will contact your doctor.

If your request is approved, your doctor can then arrange for you to have the treatment. If the IPFR panel decides not to pay for the treatment, your doctor will explain why. They will tell you about how you might be able to appeal against the decision, or what other treatment options may be available.

What happens next?

If your IPFR is refused, you or your doctor can ask for a review of the decision. You do this by completing a review request form within 25 working days of getting the decision. You can ask for a review if you feel that the panel did not consider the evidence you sent, or did not follow the correct process. You can only request a review if your doctor agrees. The review will decide 1 of the following:

  • The IPFR panel’s decision was correct and the treatment will not be funded.
  • The IPFR panel should discuss your request again.

If the final decision is not to pay for the drug, you cannot ask for another review. But you can use the NHS complaints procedure or contact the Public Services Ombudsman for Wales. You can also seek legal advice.

There may also be other things you can do if a treatment is not available.

If you live in Northern Ireland

If you live in Northern Ireland and a treatment is not funded by the Strategic Planning and Performance Group (SPPG), you can ask them to pay for it. This is called an individual funding request (IFR).

Your cancer doctor completes the IFR application form for you and sends it to the SPPG, with any supporting information.

The IFR application form requires information about:

  • your medical situation
  • your previous treatments
  • the treatment you are applying for
  • other standard treatments
  • the reasons why this treatment may be useful in your situation
  • any research that supports this
  • why you are more likely to benefit from this treatment than other patients with a similar illness.

What happens next?

The IFR Regional Scrutiny Committee usually meets every week to discuss IFRs from all the Health and Social Care Trusts. It will contact your cancer doctor if it needs more information to help decide about your IFR. When it has made a decision, it will let your cancer doctor know within 1 week of the meeting.

If your request is approved, your doctor can arrange for you to have the treatment. If the IFR committee decides not to support the request, it will explain why.

Making an appeal

If your cancer doctor has new evidence that could change the decision, they can ask the IFR Committee to discuss your IFR again. If the decision does not change, your cancer doctor can ask for an appeal of the IFR Committee’s decision by a separate appeal panel. They can ask for a review if they feel that the panel did not make a reasonable decision or did not follow the correct process. Your doctor must do this in writing within 30 days of the Committee’s decision letter.

The review will decide 1 of the following:

  • The IFR Committee’s decision was correct and the treatment will not be funded
  • The IFR Committee should discuss your IFR again within 10 working days.

If the final decision is not to pay for the treatment, you cannot ask for another review unless new evidence becomes available. If you are still unhappy, you can follow the SPPG complaints procedure or contact the Public Services Ombudsman for Northern Ireland. You can also seek legal advice.

There may also be other things you can do if a treatment is not available.

Other things you can do if a treatment is not available

There may be other things you can do if a treatment is not available. 

Contact your local Member of Parliament

MPs are elected by local people to make sure their voices are heard and represented in parliament.

Your MP could help in a range of different ways, including writing to the Chief Executive of a hospital trust, raising an issue with the relevant government department, or asking questions at Prime Minister’s Questions. You can contact your local:

If you explain your situation, they may be able to provide support.

Contact an organisation

Some national organisations campaign about access to treatment on the NHS. If there is an organisation that campaigns about the treatment or the type of cancer you have, they may be able to give you advice. They may also put you in touch with other people who have been through this process. These people can share their experiences with you and offer their support.

You can also talk to people who know what you are going through on our Online Community.

Paying for your own treatment

You may choose to pay for private cancer treatment yourself. Private healthcare is provided by independent companies and is separate to the NHS.

Private healthcare usually includes the cost of treatment, drugs and all the care you receive.

Cancer treatments often cost thousands of pounds. Your cancer doctor must still agree to prescribe the drug or treatment. This is a serious decision, so you might want to discuss it in detail with your cancer team, and family or friends.

Health insurance may pay for cancer treatment, but usually only if you already have a policy before the cancer diagnosis. Some policies will not pay for certain cancer treatments, or may only pay for 1 course of the treatment. Your insurer can give you detailed information based on your situation and private healthcare policy.

We have more information about insurance and cancer.

You can find out more about private healthcare from the Patients Association.

Having treatment abroad

Some people, especially those waiting a long time for cancer treatment, may wish to travel to another country to have treatment sooner.

If you are considering having cancer treatment in another country, it is important to understand how it works and how it will be funded.

It is important to discuss any plans with your cancer doctor before making any final decisions about travel or medical arrangements. Your cancer doctor can direct you to your Integrated Care Board, Health Board or Health and Social Care Trust. They can explain your funding options, and which one would suit you best.

S2 funding route

Some people may be able to use the S2 funding route to access some treatments.

This is a direct funding arrangement between the NHS and the state-funded healthcare provider in another country.

The S2 funding route allows you to have treatment in another European Economic Area (EEA) country, or Switzerland, under the same conditions of care and payment as the residents of that country.

In some EEA countries, you might still need to pay for some of the treatment. This is because some countries only cover a percentage of the costs. But you may be able to claim some or all of the money back when you return to the UK.

You can find more information about the S2 funding route on the NHS website.

Paying for alternative therapies

Some people may decide to pay for alternative therapies offered by private clinics in the UK and abroad. Alternative therapies (also known as alternative medicine) may claim to actively treat or even cure cancer. But there is no scientific proof to support these claims. False claims about alternative therapies have sometimes led people to refuse cancer treatments that could have helped.

No alternative therapies have ever been proven to cure cancer or slow its growth.

It is important to know exactly what each treatment involves and why it is not available on the NHS. Unlike treatments given on the NHS, many of these treatments have not been through clinical trials. Some may do more harm than good, or stop other cancer treatments from working as well.

If you are considering using alternative therapies, talk to your cancer team before making any decisions.

If you decide to use alternative therapies, it is important to check they are safe. Always check the therapist’s qualifications. Alternative therapies can be expensive, and some can cause serious side effects. They can also make you feel unwell and be harmful to your health.

We have more information about alternative therapies.

Co-payment (or top-up payments)

Sometimes people pay for a private treatment while they are also having NHS treatment. This is called co-payment or topping up. This system should only be used when there is no other way of getting the treatment within the NHS. Your doctor must still agree to prescribe the drug or treatment.

As well as paying for the treatment or drug, you will also be asked to pay for any related costs. This includes staff time and any tests or scans you need because of the treatment.

The NHS care and the private care should be given separately. This means you might have the private treatment at a different hospital, or in a private area at your usual hospital.

You can top up your treatment by paying for it yourself, or through an insurance policy. Some insurance companies have policies that cover NHS co-payments. The process for co-payments may vary in different areas of the UK. Your cancer doctor can tell you more about the process in your area.

Clinical trials

Another way you may be able to access specific treatments is by taking part in a clinical trial.

Clinical trials are a type of medical research involving people. They are important because they show which treatments are most effective and safe. This helps healthcare teams plan the best treatment for the people they care for.

Trials may test how effective a new treatment is compared to the current treatment used. Or they may get information about the safety and side effects of treatments.

Some trials help answer questions about treatments we already use. They may test whether combining treatments is more effective. Or they may research different ways to give a treatment so it works better or causes fewer side effects.

Clinical trials also research other areas of cancer care. These include diagnosis and managing side effects or symptoms.

We have more information about cancer clinical trials on our website.

About our information

  • This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been approved by members of Macmillan’s Centre of Clinical Expertise.

    Our cancer information has been awarded the PIF TICK. Created by the Patient Information Forum, this quality mark shows we meet PIF’s 10 criteria for trustworthy health information.

The language we use

We want everyone affected by cancer to feel our information is written for them.

We want our information to be as clear as possible. To do this, we try to:

  • use plain English
  • explain medical words
  • use short sentences
  • use illustrations to explain text
  • structure the information clearly
  • make sure important points are clear.

We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.

You can read more about how we produce our information here.

Date reviewed

Reviewed: 01 July 2023
|
Next review: 01 July 2026
Trusted Information Creator - Patient Information Forum
Trusted Information Creator - Patient Information Forum

Our cancer information meets the PIF TICK quality mark.

This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.